Schedule 13D ownership disclosure

SpyGlass Pharma, Inc.

Common Stock, par value $0.00001 per share · CUSIP: 85220G109

Event date: 2026-02-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Vensana Capital I GP, LLCReported CIK 0001854073

    Shares: 3,310,619 · Class: 9.9%

  • Vensana Capital I, L.P.Reported CIK 0001757539

    Shares: 3,310,619 · Class: 9.9%

  • Kirk NielsenReported CIK 0001523522

    Shares: 3,312,141 · Class: 9.9%

  • Peter Justin KleinReported CIK 0001608710

    Shares: 3,310,619 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-045048
Form type
SCHEDULE 13D
Filer
SpyGlass Pharma, Inc.
CIK
CIK 1778922
Filed
Feb 10, 2026
Reporting period
Feb 09, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub